The scar tissue can negatively affect how the medication will work
Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports [PMID: 37026881] Laboratory literature summary: Dermal Hypersensitivity Reaction to Semaglutide: Two Case Reports
Insulin resistance, hyperinsulinemia, dyslipidaemia, and obesity precede the progression to T2D in 7585 % of patients [65], and the presence of MetS increases up to fivefold the risk for T2D compared to individuals without MetS [66, 67]
The major adverse cardiovascular events (MACEs) they considered were non-fatal stroke, myocardial infarction, or cardiovascular death
Doctors usually start patients on a lower dose to help minimize side effects and increase the dose slowly
Aetna may cover Wegovy, depending on your specific plan